Jacobson, E
A consultation with a provider can assist with determining the best schedule for you
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
declares that he has received honoraria from Abbvie, Aguettant, Asdia Biogen, Ever Pharma, Ipsen, Merz, Orkyn, Reata Pharmaceuticals and Teva
Without adequate selenium, glutathione can't efficiently neutralize peroxides
AOD-9604 (Advanced Obesity Drug 9604) addresses this challenge through remarkable selectivity